Wysenski Nancy
Insider CIK 1294596 · INO Director · CYTK Director · TTPH Director · ALKS Director · DOVA Director · PRVB Director · VRTX EVP, Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CYTK CYTOKINETICS INC | A Award | 2026-10-16 | 2026-10-20 | 97 | $63.92 | $6.2K | 34,089 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2026-07-15 | 2026-07-16 | 75 | $82.62 | $6.2K | 33,992 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award deriv | 2026-05-27 | 2026-05-27 | 4,301 | — | $0 | 4,301 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2026-05-27 | 2026-05-27 | 2,851 | — | $0 | 33,917 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2026-04-15 | 2026-04-15 | 95 | $65.37 | $6.2K | 31,066 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2026-01-15 | 2026-01-16 | 98 | $63.44 | $6.2K | 30,971 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2025-10-15 | 2025-10-16 | 99 | $62.80 | $6.2K | 30,873 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2025-07-15 | 2025-07-16 | 164 | $38.01 | $6.2K | 30,774 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award deriv | 2025-05-14 | 2025-05-14 | 10,880 | — | $0 | 10,880 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2025-05-14 | 2025-05-14 | 7,333 | — | $0 | 30,610 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2025-04-15 | 2025-04-16 | 162 | $38.56 | $6.2K | 23,277 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2025-01-02 | 2025-01-06 | 127 | $48.93 | $6.2K | 23,115 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2024-10-01 | 2024-10-03 | 118 | $52.60 | $6.2K | 22,988 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2024-07-01 | 2024-07-03 | 114 | — | $0 | 22,870 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award deriv | 2024-05-15 | 2024-05-16 | 3,636 | — | $0 | 3,636 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2024-05-15 | 2024-05-16 | 5,600 | — | $0 | 22,756 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2024-01-02 | 2024-01-03 | 74 | $84.12 | $6.2K | 17,156 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2023-10-02 | 2023-10-03 | 224 | $27.88 | $6.2K | 17,082 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2023-07-07 | 2023-07-10 | 5,957 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2023-07-07 | 2023-07-10 | 1,430 | $29.88 | $42.7K | 20,356 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2023-07-07 | 2023-07-10 | 5,957 | — | $0 | 21,786 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2023-07-03 | 2023-07-05 | 187 | $33.36 | $6.2K | 16,858 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2023-06-29 | 2023-06-30 | 5,985 | — | $0 | 5,985 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2023-06-29 | 2023-06-30 | 12,732 | — | $0 | 12,732 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award deriv | 2023-05-10 | 2023-05-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2023-05-10 | 2023-05-18 | 5,000 | — | $0 | 16,671 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2023-05-09 | 2023-05-10 | 35,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2023-05-09 | 2023-05-10 | 6,250 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2023-05-09 | 2023-05-10 | 6,250 | $31.13 | $194.6K | 57,079 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2023-05-09 | 2023-05-10 | 41,250 | $31.24 | $1.29M | 15,829 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2023-05-09 | 2023-05-10 | 35,000 | $31.13 | $1.09M | 50,829 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 128,981 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 33,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 23,000 | — | $0 | 0 | SEC↗ |
| PRVB Provention Bio, Inc. | D To issuer deriv | 2023-04-27 | 2023-04-27 | 22,200 | — | $0 | 0 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2023-04-03 | 2023-04-05 | 149 | $37.71 | $5.6K | 11,671 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2023-01-03 | 2023-01-04 | 126 | $44.35 | $5.6K | 11,522 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2022-10-03 | 2022-10-05 | 110 | $51.11 | $5.6K | 11,396 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2022-07-07 | 2022-07-08 | 5,957 | — | $0 | 5,957 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2022-07-07 | 2022-07-08 | 11,554 | — | $0 | 11,554 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2022-07-01 | 2022-07-12 | 137 | $41.00 | $5.6K | 11,286 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2022-06-14 | 2022-06-16 | 7,585 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2022-06-14 | 2022-06-16 | 695 | $27.19 | $18.9K | 15,829 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2022-06-14 | 2022-06-16 | 7,585 | — | $0 | 16,524 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2022-05-17 | 2022-05-18 | 33,000 | — | $0 | 33,000 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award deriv | 2022-05-10 | 2022-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2022-05-10 | 2022-05-11 | 5,000 | — | $0 | 11,149 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2022-04-01 | 2022-04-01 | 146 | $38.38 | $5.6K | 6,149 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2022-01-03 | 2022-01-04 | 122 | $46.00 | $5.6K | 6,003 | SEC↗ |
| ALKS | M Exercise deriv | 2021-12-02 | 2021-12-03 | 5,578 | — | $0 | 0 | SEC↗ |
| ALKS | M Exercise | 2021-12-02 | 2021-12-03 | 5,578 | — | $0 | 10,278 | SEC↗ |
| ALKS | F Tax w/h | 2021-12-02 | 2021-12-03 | 1,339 | $22.11 | $29.6K | 8,939 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2021-10-01 | 2021-10-04 | 153 | $36.74 | $5.6K | 5,881 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2021-07-07 | 2021-07-08 | 31 | $19.77 | $613 | 5,728 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2021-07-01 | 2021-07-02 | 238 | $20.98 | $5.0K | 5,697 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2021-06-14 | 2021-06-16 | 7,585 | — | $0 | 7,585 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2021-06-14 | 2021-06-16 | 15,677 | — | $0 | 15,677 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2021-05-20 | 2021-05-21 | 6,104 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2021-05-20 | 2021-05-21 | 6,104 | — | $0 | 6,104 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2021-05-20 | 2021-05-21 | 1,404 | $21.92 | $30.8K | 4,700 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award deriv | 2021-05-12 | 2021-05-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2021-05-12 | 2021-05-14 | 23,000 | — | $0 | 23,000 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2021-05-12 | 2021-05-13 | 5,000 | — | $0 | 5,459 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2021-04-01 | 2021-04-05 | 204 | $24.44 | $5.0K | 459 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award | 2021-01-04 | 2021-01-05 | 255 | $19.56 | $5.0K | 255 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-12-02 | 2020-12-04 | 5,578 | — | $0 | 5,578 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-12-02 | 2020-12-04 | 11,509 | — | $0 | 11,509 | SEC↗ |
| CYTK CYTOKINETICS INC | A Award deriv | 2020-11-20 | 2020-11-20 | 35,000 | $15.99 | $559.6K | 35,000 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2020-07-15 | 2020-07-16 | 22,200 | — | $0 | 22,200 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-05-20 | 2020-05-22 | 12,823 | — | $0 | 12,823 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-05-20 | 2020-05-22 | 6,104 | — | $0 | 6,104 | SEC↗ |
| PRVB Provention Bio, Inc. | A Award deriv | 2020-05-19 | 2020-05-21 | 128,981 | — | $0 | 128,981 | SEC↗ |
| ALKS Alkermes plc. | P Buy | 2020-02-24 | 2020-02-25 | 6,940 | $19.65 | $136.4K | 11,242 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | D To issuer deriv | 2019-11-12 | 2019-11-12 | 10,000 | — | $0 | 0 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | D To issuer | 2019-11-12 | 2019-11-12 | 6,274 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2019-06-10 | 2019-06-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2019-05-22 | 2019-05-23 | 22,400 | — | $0 | 22,400 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | A Award deriv | 2019-04-26 | 2019-04-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALKS Alkermes plc. | P Buy | 2019-03-14 | 2019-03-18 | 445 | $33.06 | $14.7K | 4,302 | SEC↗ |
| ALKS Alkermes plc. | P Buy | 2019-02-21 | 2019-03-18 | 3,857 | $33.09 | $127.6K | 3,857 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | A Award | 2019-02-05 | 2019-02-07 | 6,274 | — | $0 | 6,274 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | A Award deriv | 2018-06-25 | 2018-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2018-05-30 | 2018-06-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2018-05-23 | 2018-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2017-05-31 | 2017-06-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2017-05-24 | 2017-05-25 | 14,200 | — | $0 | 14,200 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2016-06-08 | 2016-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2016-05-25 | 2016-05-26 | 21,600 | — | $0 | 21,600 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2016-05-13 | 2016-05-16 | 10,000 | $9.33 | $93.3K | 10,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2016-05-13 | 2016-05-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2016-05-08 | 2016-05-09 | 5,000 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2016-05-08 | 2016-05-09 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2015-06-10 | 2015-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2015-05-27 | 2015-05-29 | 16,000 | — | $0 | 16,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2015-05-08 | 2015-05-08 | 7,500 | $8.01 | $60.1K | 7,500 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2015-05-08 | 2015-05-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2015-03-05 | 2015-03-09 | 18,750 | $7.56 | $141.8K | 18,750 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2014-05-28 | 2014-05-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2014-03-10 | 2014-03-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2013-08-01 | 2013-08-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2013-05-15 | 2013-05-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2013-05-15 | 2013-05-17 | 6,250 | — | $0 | 6,250 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-14 | 2012-05-16 | 4,531 | — | $0 | 67,969 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-14 | 2012-05-16 | 147,071 | — | $0 | 32,929 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-14 | 2012-05-16 | 25,000 | — | $0 | 43,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-14 | 2012-05-16 | 3,398 | — | $0 | 37,383 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-14 | 2012-05-16 | 147,071 | $39.70 | $5.84M | 183,834 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-14 | 2012-05-16 | 4,531 | $37.86 | $171.5K | 36,763 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-14 | 2012-05-16 | 372 | $65.00 | $24.2K | 32,232 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-14 | 2012-05-16 | 25,000 | $39.70 | $992.5K | 208,832 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-14 | 2012-05-16 | 3,398 | $38.80 | $131.8K | 212,232 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-14 | 2012-05-16 | 179,628 | $64.27 | $11.54M | 32,604 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-14 | 2012-06-01 | 179,628 | $64.27 | $11.54M | 32,604 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-14 | 2012-06-01 | 372 | $65.00 | $24.2K | 32,232 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-09 | 18,750 | — | $0 | 68,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-09 | 9,063 | — | $0 | 20,390 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-09 | 10,196 | — | $0 | 40,781 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-08 | 2012-05-09 | 18,750 | $63.52 | $1.19M | 31,394 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-08 | 2012-05-09 | 10,196 | $62.08 | $633.0K | 50,144 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-08 | 2012-05-09 | 9,063 | $59.19 | $536.4K | 60,340 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-09 | 18,750 | $39.70 | $744.4K | 69,403 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-09 | 9,063 | $33.82 | $306.5K | 40,457 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-09 | 10,196 | $38.80 | $395.6K | 50,653 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-07 | 2012-05-09 | 12,500 | — | $0 | 87,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-07 | 2012-05-09 | 120,000 | — | $0 | 180,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-07 | 2012-05-09 | 3,398 | — | $0 | 50,977 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-07 | 2012-05-09 | 6,797 | — | $0 | 29,453 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-07 | 2012-05-09 | 3,398 | $38.80 | $131.8K | 179,089 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-07 | 2012-05-09 | 120,000 | $39.70 | $4.76M | 175,691 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-07 | 2012-05-09 | 12,500 | $39.70 | $496.3K | 55,691 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-07 | 2012-05-09 | 147,695 | $54.50 | $8.05M | 31,394 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-07 | 2012-05-09 | 6,797 | $33.82 | $229.9K | 43,191 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2012-02-02 | 2012-02-06 | 72,500 | — | $0 | 72,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2012-02-02 | 2012-02-06 | 14,501 | $0.01 | $145 | 36,394 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-01-19 | 2012-01-23 | 6,042 | $37.00 | $223.6K | 21,893 | SEC↗ |